Please click here to download the full Funding Overview and Application Instructions. Please click here to download the Proposal and the budget spreadsheet for submissions. Proposals and budgets must also be submitted as separate Word and Excel spreadsheet documents. For the next funding cycle, Call for Proposals will be announced in the Fall of 2016 with proposals due in early 2017.

Each proposal will be evaluated on the basis of

  • scientific merit
  • potential health care impact and significance
  • potential for commercial exits within 24 months of funding (potential for successfully obtaining angel or venture capital financing for a new company formed around the technology or licensing of the IP to a medical device, pharmaceutical or diagnostics company)

Additionally, projects funded through Coulter will need to demonstrate:

  • Clearly envisioned medical product concepts that meet unmet medical needs
  • Translational research plans to de-risk key technical hurdles and address commercial questions
  • Industry or investor interest
  • Clear path to company formation, angel / venture capital funding, or to direct licensing.

Proposals demonstrating the ability to meet these objectives will receive greater consideration for funding.

Review process

  • Proposals will be triaged internally, and successful candidates will be invited to make a five minute “elevator pitch“ to the UM Coulter Oversight Committee at a meeting in March.
  • Finalists will be notified by mid-March as to whether they will be invited to participate in the C3i program. The C3i program is an 8-week commercialization planning program (see About Us).
  • A final presentation to the Oversight Committee at the Final Review Meeting in late May/early June.
  • Funding will begin July 1, 2016.

Application instructions

Funding application submission packets for Coulter Program funding must be submitted to Coulter Program Director, Thomas Marten ( as a single PDF document. Funding application submissions need to include the proposal, budget, literature references, and NIH style biosketches. The proposal and budget will also need to be submitted as separate documents.  It is strongly suggested that applicants discuss their proposal with the Coulter Program Director Thomas Marten (; 734-647-1680) prior to submission to explore the commercial potential for your project and fit for Coulter funding opportunities. Proposals are due by 5 pm on Friday, February 1st, 2016.

Each proposal must have Co-PI’s, at least one of whom has an appointment in the College of Engineering (COE) at the University of Michigan and at least one clinical investigator from a clinical department at the University of Michigan. The research must relate directly to the development of new products with applications in health care.  The objectives of the project should include milestones that provide technical and commercial de-risking to generate professional investor interest.

Funding submission packet – This will include the following information compiled into a single pdf document.

  1. Proposal (7 pages, 10 pt. font minimum.)
  • Please follow the template for the research proposal which can be downloaded on the Coulter Website here: FY2017-Proposal-Template- The Proposal must also be submitted as a separate Word document.
  1. Budget Spreadsheet
  • Please follow the template for the budget which can be downloaded on the Coulter Website here: Coulter_2016_Proposal_budget . The budget must also be submitted as a separate Excel document.
  • Projects are funded for 1-year time periods at at the $100,000 range, though larger and smaller requests will be considered.
    • Requests for larger amounts should be discussed with Thomas Marten, Coulter Program Director.
    • Seed grants not exceeding $25,000 may also be considered for projects requiring finite achievements (i.e. generation of data or a prototype necessary to apply for subsequent translational funding).
  • Allowable budget expenditures include: salary and fringe benefits for project personnel, materials and supplies, equipment, and pre-negotiated travel.
  • Budget line items for outside consultants (i.e. regulatory and market research) and prototype manufacturing are allowable, but will be managed through the Coulter CPD short code.
  • The clinical co-PI must be included in the budget and his/her budget percentage MAY be cost-shared with the clinical department. Typically 5% to 10% of a clinical collaborator’s salary is budgeted, of which up to half will be charged to the Coulter grant and at least half will be cost shared with the clinical department.
  • There are no guidelines for acceptable percent effort for the COE co-PI.
  • Combined co-PI salaries and benefits should not exceed 20% of the total project budget.
  • Tuition for graduate students is allowable based on graduate student effort level on the project. Large tuition line items on budgets are discouraged. See budget template for additional details.
  • Large capital purchases are prohibited. Funds may not be used for construction or renovation.
  • A department signature is required on the bottom of the budget, for any cost share commitment.
  1. References/Literature cited 
  1. NIH-style Biosketches
  • Biosketches for PIs and key personnel involved in the project should be attached to this document as supplemental material.